Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 09, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Releases Preliminary Data Demonstrating its Unyvero HPN Panel for Pneumonia Identifies Life-Threatening Bacterial Co-Infections in COVID-19 Patients in Just Five Hours

Performance of the Unyvero HPN Panel for pneumonia proves to be strongly concordant (98.2%) compared to bacterial lower respiratory tract culture Collaboration with Karolinska Institutet highlights...
June 03, 2020 06:00 ET | Source: OpGen, Inc.

OpGen Expands Partnership with New York State Department of Health and IDC to Detect Antimicrobial-Resistant Infections

Collaboration with NYS Department of Health’s Wadsworth Center continues for second year term Project to utilize OpGen’s Acuitas® AMR Gene Panel and Acuitas Lighthouse® Software within digital health...
October 23, 2019 07:30 ET | Source: OpGen, Inc.

U.S. Patent Allowed Covering Acuitas Lighthouse® Software

GAITHERSBURG, Md., Oct. 23, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that the United States Patent and Trademark Office (the “USPTO”) has allowed a key OpGen patent...
October 07, 2019 07:30 ET | Source: OpGen, Inc.

OpGen Presents Preliminary Acuitas® AMR Gene Panel Data for Detecting Urinary Tract Infections

GAITHERSBURG, Md., Oct. 07, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) today announced the presentation of preliminary data at IDWeek 2019 for the Company’s Acuitas® AMR Gene Panel and...
September 18, 2019 07:30 ET | Source: OpGen, Inc.

OpGen Provides update on Curetis Group’s R&D Collaboration

Curetis R&D collaboration to develop NGS-based predictive antibiotic resistance testing powered by ARESdbCollaborator to fund R&D and obtains option to license ARESdb and ARES Technology...
September 04, 2019 06:55 ET | Source: OpGen, Inc.

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

Combined company creates a commercial-stage, transatlantic diagnostics company focusing on data-driven solutions for molecular microbiologyCombined company to be headquartered in Gaithersburg, MD,...
June 27, 2019 07:30 ET | Source: OpGen, Inc.

OpGen’s Acuitas® AMR Gene Panel Shows Potential for Reducing Total Time to Targeted Therapy

Collaborator data demonstrating OpGen’s rapid prediction of antibiotic resistance and detection of uropathogens presented at ASM Microbe 2019 GAITHERSBURG, Md., June 27, 2019 (GLOBE NEWSWIRE) --...